Photobiomodulation therapy inhibits oral submucous fibrosis in mice

OBJECTIVES: Oral submucous fibrosis (OSMF) is a chronic inflammatory disease and a potentially malignant oral disorder. However, the best therapeutic treatment for OSMF remains uncertain. Our previous study showed that photobiomodulation (PBM) therapy and forskolin could reduce arecoline‐induced fib...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oral Dis
Egile Nagusiak: Chiang, Min‐Hsuan, Lee, Kun‐Tsung, Chen, Chia‐Hsin, Chen, Ker‐Kong, Wang, Yan‐Hsiung
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2020
Gaiak:
Oral Mucosa
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7540580/
https://ncbi.nlm.nih.gov/pubmed/32391600
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/odi.13409
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak